102 related articles for article (PubMed ID: 22088547)
1. Hashimoto encephalopathy: a case report with proton MR spectroscopic findings.
Su TH; Jin EH; He W
Chin Med J (Engl); 2011 Oct; 124(20):3420-2. PubMed ID: 22088547
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
[TBL] [Abstract][Full Text] [Related]
3. Time course of Hashimoto's encephalopathy revealed by MRI: report of two cases.
Chen N; Qin W; Wei C; Wang X; Li K
J Neurol Sci; 2011 Jan; 300(1-2):169-72. PubMed ID: 20943237
[TBL] [Abstract][Full Text] [Related]
4. Experimental hypoxic-ischemic encephalopathy: comparison of apparent diffusion coefficients and proton magnetic resonance spectroscopy.
Li YK; Liu GR; Zhou XG; Cai AQ
Magn Reson Imaging; 2010 May; 28(4):487-94. PubMed ID: 20071123
[TBL] [Abstract][Full Text] [Related]
5. Reversible focal splenium lesion--MRS study of a different etiology.
Lin YW; Yu CY
Acta Neurol Taiwan; 2009 Sep; 18(3):203-6. PubMed ID: 19960965
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
Qiu SJ; Zhang XL; Zhang Y; Jiang M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
[TBL] [Abstract][Full Text] [Related]
9. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
10. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
14. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
15. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
17. [Proton MRS in a case of intracerebellar epidermoid].
Isobe T; Matsumura A; Anno I; Yoshizawa T; Itai Y; Nose T
No To Shinkei; 2002 Feb; 54(2):163-6. PubMed ID: 11889764
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging and proton MR spectroscopy of the brain in a patient with carbohydrate-deficient glycoprotein syndrome type I.
Takeuchi M; Harada M; Hisaoka S; Nishitani H; Mori K; Sakama M
J Magn Reson Imaging; 2003 Jun; 17(6):722-5. PubMed ID: 12766902
[TBL] [Abstract][Full Text] [Related]
19. [Neuroradiological study of a possible progressive multifocal leukoencephalopathy using diffusion tensor imaging and proton magnetic resonance spectroscopy].
Matsui N; Nakane S; Harada M; Furutani K; Izumi Y; Oka H; Hashimoto C; Kaji R
Rinsho Shinkeigaku; 2006 Aug; 46(8):555-60. PubMed ID: 17154035
[TBL] [Abstract][Full Text] [Related]
20. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
